Neurologic complications of the reactivation of varicella-zoster virus

New England Journal of Medicine

Volumn 342, Issue 9, 2000, Pages 635-645

  Gilden, Donald H ^a   Kleinschmidt DeMasters, B K ^a   LaGuardia, James J ^a   Mahalingam, Ravi ^a   Cohrs, Randall J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ADENOSINE PHOSPHATE; ALPHAN3 INTERFERON; AMANTADINE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BENSERAZIDE; CARBAMAZEPINE; CODEINE; DOPAMINE RECEPTOR STIMULATING AGENT; FAMCICLOVIR; HORMONE; IMMUNOGLOBULIN; LEVODOPA; NARCOTIC AGENT; NORTRIPTYLINE; PARACETAMOL; PHENYTOIN; PREDNISOLONE; PREDNISONE; STEROID; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VIRUS DNA; VITAMIN;

BRAIN VENTRICULITIS; CELL TYPE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; ENCEPHALITIS; HERPES ZOSTER; HUMAN; LATENT PERIOD; MENINGITIS; MYELITIS; NEUROLOGIC DISEASE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CHICKENPOX; DNA, VIRAL; ENCEPHALITIS; GANGLIA; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MENINGITIS, ASEPTIC; NEURALGIA; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0034594882     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200003023420906     Document Type: Review

References (100)

1. Weller TH. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med 1983;309:1362-8.
2. Idem. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med 1983;309:1434-40.
3. Plotkin SA, Stein S, Snyder M, Immesoete P. Attempts to recover varicella virus from ganglia. Ann Neurol 1977;2:249.
4. Gilden DH, Vafai A, Shtram Y, Becker Y, Devlin M, Wellish M. Varicella-zoster virus DNA in human sensory ganglia. Nature 1983;306:478-80.
5. Hyman RW, Ecker JR, Tenser RB. Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 1983;2:814-6.
6. Gilden DH, Rozenman Y, Murray R, Devlin M, Vafai A. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann Neurol 1987;22:377-80.
7. Mahalingam R, Wellish M, Wolf W, et al. Latent varicella-zoster virus DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990;323: 627-31.
8. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
9. Mahalingam R, Wellish M, Lederer D, Forghani B, Cohrs R, Gilden DH. Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol 1993;67:2381-4.
10. Clarke P, Beer T, Cohrs R, Gilden DH. Configuration of latent varicella-zoster virus DNA. J Virol 1995;69:8151-4.
11. Efstathiou SE, Minson AC, Field HJ, Anderson JR, Wildy P. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol 1986;57:446-55.
12. Mellerick DM, Fraser NW. Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology 1987;158:265-75.
13. Cohrs R, Barbour M, Gilden DH. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol 1996;70:2789-96.
14. Mahalingam R, Wellish M, Cohrs R, et al. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A 1996;93:2122-4.
15. Lungu O, Panagiotidis CA, Annunziato PW, Gershon AA, Silverstein SJ. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc Natl Acad Sci U S A 1998;95:7080-5.
16. Croen KD, Ostrove JM, Dragovic LJ, Straus SE. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A 1988; 85:9773-7.
17. Meier JL, Straus SE. Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters. J Virol 1993;67:7573-81.
18. Lungu O, Annunziato PW, Gershon A, et al. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci U S A 1995;92:10980-4.
19. Dueland AN, Ranneberg-Nilsen T, Degre M. Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization. Arch Virol 1995;140:2055-66.
20. Kennedy PG, Grinfeld E, Gow JW. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 1998;95:4658-62.
21. LaGuardia JJ, Cohrs RJ, Gilden DH. Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol 1999;73:8571-7.
22. Gelb LD, Donner DE, Gershon AA, et al. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J Infect Dis 1987;155:633-40.
23. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998;178:Suppl 1:S109-S112.
24. Guess HA, Broughton DD, Melton LJ III, Kurland LT. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985;76:512-7.
25. Manz HJ, Canter HG, Melton J. Trigeminal herpes zoster causing mandibular osteonecrosis and spontaneous tooth exfoliation. South Med J 1986;79:1026-8.
26. Garty B-Z, Dinari G, Sarnat H, Cohen S, Nitzan M. Tooth exfoliation and osteonecrosis of the maxilla after trigeminal herpes zoster. J Pediatr 1985;106:71-3.
27. Carroll WM, Mastaglia FL. Optic neuropathy and ophthalmoplegia in herpes zoster oticus. Neurology 1979;29:726-9.
28. Crabtree JA. Herpes zoster oticus. Laryngoscope 1968;78:1853-78.
29. Steffen R, Selby G. "Atypical" Ramsay Hunt syndrome. Med J Aust 1972;1:227-30.
30. Lapresle I, Lasjaunias P. Cranial nerve ischaemic arterial syndromes: a review. Brain 1986;109:207-16.
31. Mayberg MR, Zervas NT, Moskowitz MA. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horse-radish peroxidase histochemistry. J Comp Neurol 1984;223:46-56.
32. Thomas JE, Howard FM. Segmental zoster paresis - a disease profile. Neurology 1972;22:459-66.
33. Stowasser M, Cameron J, Oliver WA. Diaphragmatic paralysis following cervical herpes zoster. Med J Aust 1990;153:555-6.
34. Arnold DG. Herpes zoster as sequel of spinal anesthesia. J Int Coll Surg 1941;4:66-7.
35. Denny-Brown D, Adams RD, Fitzgerald PJ. Pathologic features of herpes zoster: note on "geniculate herpes." Arch Neurol Psychiatry 1944;51: 216-31.
36. Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986;20: 651-64.
37. Watson CPN. Herpes zoster and postherpetic neuralgia. Vol. 8 of Pain research and clinical management. Amsterdam: Elsevier, 1993.
38. Bowsher D. Post-herpetic neuralgia in older patients: incidence and optimal treatment. Drugs Aging 1994;5:411-8.
39. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment, and prevention. N Engl J Med 1996;335:32-42.
40. Tyring S, Nahlik J, Cunningham A, et al. Efficacy and safety of famciclovir in the treatment of patients with herpes zoster: results of the first placebo-controlled study. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 17-20, 1993. Washington, D.C.: American Society for Microbiology, 1993:400. abstract.
41. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900.
42. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975; 25:571-5.
43. De Moragas JM, Kierland RR. The outcome of patients with herpes zoster. Arch Dermatol 1957;75:193-6.
44. Rogers RS III, Tindall JP. Geriatric herpes zoster. J Am Geriatr Soc 1971;19:495-504.
45. Brown GR. Herpes zoster: correlation of age, sex, distribution, neuralgia, and associated disorders. South Med J 1976;69:576-8.
46. Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med 1978;298:981-7.
47. McKendrick MW, McGill JI, Wood MJ. Lack of effect of acyclovir on postherpetic neuralgia. BMJ 1989;298:431.
48. Galbraith AW. Prevention of post-herpetic neuralgia by amantadine hydrochloride (Symmetrel). Br J Clin Pract 1983;37:304-6.
49. Sklar SH, Blue WT, Alexander EJ, Bodian CA. Herpes zoster: the treatment and prevention of neuralgia with adenosine monophosphate. JAMA 1985;253:1427-30.
50. Kernbaum S, Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. JAMA 1981;246:132-4.
51. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970;211: 1681-3.
52. Keczkes K, Basheer AM. Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol 1980;102:551-5.
53. Esmann V, Geil JP, Kroon S, et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet 1987;2:126-9.
54. Segal AZ, Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology 1996;46:1175-6.
55. Eide K, Stubhaug A, Oye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995;61:221-8.
56. King RB. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol 1993;50:1046-53.
57. Smith FP. Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain. Surg Neurol 1978;10:50-3.
58. Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991;44:105-17.
59. Gilden DH, Devlin ME, Wellish M, et al. Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster. Virus Genes 1988;2:299-305.
60. Mahalingam R, Wellish M, Brucklier J, Gilden DH. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1995;1:130-3.
61. Gilden DH, Beinlich BR, Rubinstien EM, et al. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 1994;44:1818-23.
62. Hogan EL, Krigman MR. Herpes zoster myelitis: evidence for viral invasion of spinal cord. Arch Neurol 1973;29:309-13.
63. Gilden DH, Dueland AN, Cohrs R, Martin JR, Kleinschmidt-DeMasters BK, Mahalingam R. Preherpetic neuralgia. Neurology 1991;41:1215-8.
64. Tako J, Rado JP. Zoster meningoencephalitis in a steroid-treated patient. Arch Neurol 1965;12:610-2.
65. de Silva SM, Mark AS, Gilden DH, et al. Zoster myelitis: improvement with antiviral therapy in two cases. Neurology 1996;47:929-31.
66. Shope TC. Chickenpox encephalitis and encephalopathy: evidence for differing pathogenesis. Yale J Biol Med 1982;55:321-7.
67. Takashima S, Becker LE. Neuropathology of fatal varicella. Arch Pathol Lab Med 1979;103:209-13.
68. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38:585-91.
69. McCormick WF, Rodnitzky RL, Schochet SS Jr, McKee AP. Varicella-zoster encephalomyelitis: a morphologic and virologic study. Arch Neurol 1969;21:559-70.
70. Nau R, Lantsch M, Stiefel M, Polak T, Reiber H. Varicella zoster virus-associated focal vasculitis without herpes zoster: recovery after treatment with acyclovir. Neurology 1998;51:914-5.
71. Kuroiwa Y, Furukawa T. Hemispheric infarction after herpes zoster ophthalmicus: computed tomography and angiography. Neurology 1981; 31:1030-2.
72. Elble RJ. Intracerebral hemorrhage with herpes zoster ophthalmicus. Ann Neurol 1983;14:591-2.
73. Hilt DC, Buchholz D, Krumholz A, Weiss H, Wolinsky JS. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 1983;14: 543-53.
74. Melanson M, Chalk C, Georgevich L, et al. Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology 1996;47:569-70.
75. Hall S, Carlin L, Roach ES, McLean WT Jr. Herpes zoster and central retinal artery occlusion. Ann Neurol 1983;13:217-8.
76. Ross MH, Abend WK, Schwartz RB, Samuels MA. A case of C2 herpes zoster with delayed bilateral pontine infarction. Neurology 1991;41: 1685-6.
77. Fukumoto S, Kinjo M, Hokamura K, Tanaka K. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke 1986;17:1024-8.
78. Geny C, Yulis J, Azoulay A, Brugieres P, Saint-Val C, Degos JD. Thalamic infarction following lingual herpes zoster. Neurology 1991;41:1846.
79. Rawlinson WD, Cunningham AL. Contralateral hemiplegia following thoracic herpes zoster. Med J Aust 1991;155:344-6.
80. Horten B, Price RW, Jimenez D. Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann Neurol 1981;9: 251-66.
81. Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LE, Gilden DH. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 1995;37:784-90.
82. Morgello S, Block GA, Price RW, Petito CK. Varicella-zoster virus leukoencephalitis and cerebral vasculopathy. Arch Pathol Lab Med 1988;112: 173-7.
83. Ryder JW, Croen K, Kleinschmidt DeMasters BK, Ostrove JM, Straus SE, Cohn DL. Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS. Ann Neurol 1986;19:182-8.
84. Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996;27:927-38.
85. Reimer LG, Beller LB. CSF in herpes zoster meningoencephalitis. Arch Neurol 1981;38:668.
86. Wolf SM. Decreased cerebrospinal fluid glucose level in herpes zoster meningitis: report of a case. Arch Neurol 1974;30:109.
87. Gilden DH, Bennet JL, Kleinschmidt-DeMasters BK, Song DD, Yee AS, Steiner I. The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci 1998;159:140-4.
88. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 1996;47:1441-6.
89. Kleinschmidt-DeMasters BK, Mahalingam R, Shimek C, et al. Profound cerebrospinal fluid pleocytosis and Froin's syndrome secondary to widespread nccrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis. J Neurol Sci 1998;159:213-8.
90. Devinsky O, Cho E-S, Petito CK, Price RW. Herpes zoster myelitis. Brain 1991;114:1181-96.
91. Lewis GW. Zoster sine herpete. BMJ 1958;2:418-21.
92. Easton HG. Zoster sine herpete causing acute trigeminal neuralgia. Lancet 1970;2:1065-6.
93. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 1994;35:530-3.
94. Amlie-Lefond C, Mackin GA, Ferguson M, Wright RR, Mahalingam R, Gilden DH. Another case ofvirologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol 1996;2:136-8.
95. Vartdal F, Vandvik B, Norrby E. Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis. J Neurol Sci 1982;57:121-32.
96. Mayo DR, Booss J. Varicella zoster-associated neurologic disease without skin lesions. Arch Neurol 1989;46:313-5.
97. Osaki Y, Matsubayashi K, Okumiya K, Wada T, Doi Y. Polyneuritis cranialis due to varicella-zoster virus in the absence of rash. Neurology 1995; 45:2293.
98. Aitken RS, Brain RT. Facial palsy and infection with zoster virus. Lancet 1933;1:19-22.
99. Dueland AN, Devlin M, Martin JR, et al. Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann Neurol 1991;29:569-72.
100. Vafai A, Mahalingam R, Zerbe G, Wellish M, Gilden DH. Detection of antibodies to varicella-zoster virus proteins in sera from the elderly. Gerontology 1988;34:242-9.